154 related articles for article (PubMed ID: 31757405)
1. Radiation induced optic neuropathy: Does treatment modality influence the risk?
Mohamed Ali A; Mathis T; Bensadoun RJ; Thariat J
Bull Cancer; 2019 Dec; 106(12):1160-1176. PubMed ID: 31757405
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced optic neuropathy after pencil beam scanning proton therapy for skull-base and head and neck tumours.
Kountouri M; Pica A; Walser M; Albertini F; Bolsi A; Kliebsch U; Bachtiary B; Combescure C; Lomax AJ; Schneider R; Weber DC
Br J Radiol; 2020 Mar; 93(1107):20190028. PubMed ID: 31322969
[TBL] [Abstract][Full Text] [Related]
3. Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways.
Milano MT; Grimm J; Soltys SG; Yorke E; Moiseenko V; Tomé WA; Sahgal A; Xue J; Ma L; Solberg TD; Kirkpatrick JP; Constine LS; Flickinger JC; Marks LB; El Naqa I
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):87-99. PubMed ID: 29534899
[TBL] [Abstract][Full Text] [Related]
4. Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy.
Li PC; Liebsch NJ; Niemierko A; Giantsoudi D; Lessell S; Fullerton BC; Adams J; Shih HA
Radiother Oncol; 2019 Feb; 131():112-119. PubMed ID: 30773177
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT).
Brecht S; Boda-Heggemann J; Budjan J; Siebenlist K; Stieler F; Steil V; Wenz F; Lohr F; Buergy D
Radiother Oncol; 2019 May; 134():166-177. PubMed ID: 31005211
[TBL] [Abstract][Full Text] [Related]
6. Combining Clinical and Dosimetric Features in a PBS Proton Therapy Cohort to Develop a NTCP Model for Radiation-Induced Optic Neuropathy.
Köthe A; van Luijk P; Safai S; Kountouri M; Lomax AJ; Weber DC; Fattori G
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):587-595. PubMed ID: 33421557
[TBL] [Abstract][Full Text] [Related]
7. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.
McDonald MW; Liu Y; Moore MG; Johnstone PA
Radiat Oncol; 2016 Feb; 11():32. PubMed ID: 26922239
[TBL] [Abstract][Full Text] [Related]
8. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity.
Bishop AJ; Greenfield B; Mahajan A; Paulino AC; Okcu MF; Allen PK; Chintagumpala M; Kahalley LS; McAleer MF; McGovern SL; Whitehead WE; Grosshans DR
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):354-61. PubMed ID: 25052561
[TBL] [Abstract][Full Text] [Related]
9. Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery.
Leavitt JA; Stafford SL; Link MJ; Pollock BE
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):524-7. PubMed ID: 24074926
[TBL] [Abstract][Full Text] [Related]
10. Exposure Risks Among Children Undergoing Radiation Therapy: Considerations in the Era of Image Guided Radiation Therapy.
Hess CB; Thompson HM; Benedict SH; Seibert JA; Wong K; Vaughan AT; Chen AM
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):978-92. PubMed ID: 27026304
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy for paranasal sinuses and base of skull tumors.
Liang ZG; Kusumawidjaja G; Kazmi F; Wee JTS; Chua MLK
Oral Oncol; 2018 Nov; 86():61-68. PubMed ID: 30409321
[TBL] [Abstract][Full Text] [Related]
12. Proton radiation therapy for head and neck cancer: a review of the clinical experience to date.
Holliday EB; Frank SJ
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):292-302. PubMed ID: 24837890
[TBL] [Abstract][Full Text] [Related]
13. Late-onset radiation-induced optic neuropathy after radiotherapy for nasopharyngeal carcinoma.
Zhao Z; Lan Y; Bai S; Shen J; Xiao S; Lv R; Zhang B; Tao E; Liu J
J Clin Neurosci; 2013 May; 20(5):702-6. PubMed ID: 23317755
[TBL] [Abstract][Full Text] [Related]
14. Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world.
Zhang W; Hu W; Hu J; Gao J; Yang J; Kong L; Lu JJ
Cancer Sci; 2020 Dec; 111(12):4465-4479. PubMed ID: 32936975
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated with Occurrence of Radiation-induced Optic Neuropathy at "Safe" Radiation Dosage.
Doroslovački P; Tamhankar MA; Liu GT; Shindler KS; Ying GS; Alonso-Basanta M
Semin Ophthalmol; 2018; 33(4):581-588. PubMed ID: 28704158
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.
Shiraishi Y; Xu C; Yang J; Komaki R; Lin SH
Radiother Oncol; 2017 Oct; 125(1):48-54. PubMed ID: 28917586
[TBL] [Abstract][Full Text] [Related]
17. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
Hoppe BS; Wolden SL; Zelefsky MJ; Mechalakos JG; Shah JP; Kraus DH; Lee N
Head Neck; 2008 Jul; 30(7):925-32. PubMed ID: 18302261
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves.
Demizu Y; Murakami M; Miyawaki D; Niwa Y; Akagi T; Sasaki R; Terashima K; Suga D; Kamae I; Hishikawa Y
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1487-92. PubMed ID: 19345516
[TBL] [Abstract][Full Text] [Related]
19. Risk of Radiation Vasculopathy and Stroke in Pediatric Patients Treated With Proton Therapy for Brain and Skull Base Tumors.
Hall MD; Bradley JA; Rotondo RL; Hanel R; Shah C; Morris CG; Aldana PR; Indelicato DJ
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):854-859. PubMed ID: 29730064
[TBL] [Abstract][Full Text] [Related]
20. Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up.
Zenda S; Kawashima M; Arahira S; Kohno R; Nishio T; Tahara M; Hayashi R; Akimoto T
Int J Clin Oncol; 2015 Jun; 20(3):447-54. PubMed ID: 25135461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
